nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Framework for Applying Health Technology Assessment in Cyprus: Thoughts, Success Stories, and Recommendations
|
Petrou, Panagiotis |
|
2013 |
2 |
2 |
p. 273-278 |
artikel |
2 |
An Audit of Diabetes-Dependent Quality of Life (ADDQOL) in Older Patients with Diabetes Mellitus Type 2 in Slovenia
|
Turk, Eva |
|
2013 |
2 |
2 |
p. 248-253 |
artikel |
3 |
Capacity Building for HTA Implementation in Middle-Income Countries: The Case of Hungary
|
Kaló, Zoltán |
|
2013 |
2 |
2 |
p. 264-266 |
artikel |
4 |
Children Hospitalized for Varicella: Complications and Cost Burden
|
Turel, Ozden |
|
2013 |
2 |
2 |
p. 226-230 |
artikel |
5 |
Clinical Burden of Invasive Pneumococcal Disease in Selected Developing Countries
|
Maimaiti, Namaitijiang |
|
2013 |
2 |
2 |
p. 259-263 |
artikel |
6 |
Copyright/Subscription
|
|
|
2013 |
2 |
2 |
p. v |
artikel |
7 |
Cost-Effectiveness Analysis of Aripiprazole Augmentation Treatment of Patients with Major Depressive Disorder Compared to Olanzapine and Quetiapine Augmentation in Turkey: A Microsimulation Approach
|
Saylan, Mete |
|
2013 |
2 |
2 |
p. 171-180 |
artikel |
8 |
Cost for Treatment of Chronic Lymphocytic Leukemia in Specialized Institutions of Ukraine
|
Mandrik, Olena |
|
2013 |
2 |
2 |
p. 205-209 |
artikel |
9 |
Costs of Medically Attended Acute Gastrointestinal Infections: The Polish Prospective Healthcare Utilization Survey
|
Czech, Marcin |
|
2013 |
2 |
2 |
p. 210-217 |
artikel |
10 |
Cost-Utility Analysis of Depot Atypical Antipsychotics for Chronic Schizophrenia in Croatia
|
Jukic, Vlado |
|
2013 |
2 |
2 |
p. 181-188 |
artikel |
11 |
Cost-Utility Analysis of Pharmaceutical Care Intervention Versus Usual Care in Management of Nigerian Patients with Type 2 Diabetes
|
Adibe, Maxwell O. |
|
2013 |
2 |
2 |
p. 189-198 |
artikel |
12 |
Dossier System as a Practical Tool for Compiling Reimbursement Lists
|
Sura, Maria V. |
|
2013 |
2 |
2 |
p. 284-289 |
artikel |
13 |
Economic Burden of Cardiovascular Diseases in the Russian Federation
|
Kontsevaya, Anna |
|
2013 |
2 |
2 |
p. 199-204 |
artikel |
14 |
Editorial Board
|
|
|
2013 |
2 |
2 |
p. IFC |
artikel |
15 |
ERRATUM
|
Priori, Stephen |
|
2013 |
2 |
2 |
p. 329-330 |
artikel |
16 |
Further Steps in the Development of Pharmacoeconomics, Outcomes Research, and Health Technology Assessment in Central and Eastern Europe, Western Asia, and Africa
|
Boncz, Imre |
|
2013 |
2 |
2 |
p. 169-170 |
artikel |
17 |
Guide for Authors
|
|
|
2013 |
2 |
2 |
p. I-II |
artikel |
18 |
Impact of the Pharma Economic Act on Diffusion of Innovation and Reduction of Costs in the Hungarian Prescription Drug Market (2007–2010)
|
Hren, Rok |
|
2013 |
2 |
2 |
p. 290-299 |
artikel |
19 |
Note from the Editors
|
Augustovski, Federico |
|
2013 |
2 |
2 |
p. 328 |
artikel |
20 |
Patient-Reported Quality of Life During Antiretroviral Therapy in a Nigerian Hospital
|
Oparah, Azuka C. |
|
2013 |
2 |
2 |
p. 254-258 |
artikel |
21 |
Performance Assessment of Ga District Mutual Health Insurance Scheme, Greater Accra Region, Ghana
|
Nsiah-Boateng, Eric |
|
2013 |
2 |
2 |
p. 300-305 |
artikel |
22 |
Radiology Services Costs and Utilization Patterns Estimates in Southeastern Europe—A Retrospective Analysis from Serbia
|
Jakovljević, Mihajlo |
|
2013 |
2 |
2 |
p. 218-225 |
artikel |
23 |
Recommendations for Reporting Pharmacoeconomic Evaluations in Egypt
|
Elsisi, Gihan H. |
|
2013 |
2 |
2 |
p. 319-327 |
artikel |
24 |
Response to Letter from Dr. Jorge Revilla Beltri dated 22nd March, 2013
|
Sandorff, Erik |
|
2013 |
2 |
2 |
p. 333 |
artikel |
25 |
Response to “Potential Regulatory and Commercial Environment for Biosimilars in Latin America” by Azevedo et al.
|
Revilla Beltri, Jorge |
|
2013 |
2 |
2 |
p. 331-332 |
artikel |
26 |
RETRACTED: Systematic Review of Economic Evaluation Literature in Ghana: Is Health Technology Assessment the Future?
|
Odame, Emmanuel Ankrah |
|
2013 |
2 |
2 |
p. 279-283 |
artikel |
27 |
Reviewer Acknowledgement
|
|
|
2013 |
2 |
2 |
p. e1-e2 |
artikel |
28 |
Table of Contents
|
|
|
2013 |
2 |
2 |
p. i-iii |
artikel |
29 |
The Impact of Pharmaceutical Care Intervention on the Quality of Life of Nigerian Patients Receiving Treatment for Type 2 Diabetes
|
Adibe, Maxwell O. |
|
2013 |
2 |
2 |
p. 240-247 |
artikel |
30 |
The Methodological Challenges for the Estimation of Quality of Life in Children for Use in Economic Evaluation in Low-Income Countries
|
Mabugu, Travor |
|
2013 |
2 |
2 |
p. 231-239 |
artikel |
31 |
The Process of Privatization of Health Care Provision in Poland
|
Kaczmarek, Krzysztof |
|
2013 |
2 |
2 |
p. 306-311 |
artikel |
32 |
Transforming Public Servants’ Health Care Organization in Greece through the Implementation of an Electronic Referral Project
|
Souliotis, Kyriakos |
|
2013 |
2 |
2 |
p. 312-318 |
artikel |
33 |
What Influences Recommendations Issued by the Agency for Health Technology Assessment in Poland? A Glimpse Into Decision Makers’ Preferences
|
Niewada, Maciej |
|
2013 |
2 |
2 |
p. 267-272 |
artikel |